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To optimize the expression, extraction and purification of plant-derived tetrameric
recombinant human butyrylcholinesterase (prBChE), we describe the development and
use of plant viral amplicon-based gene expression system; Tobacco Mosaic Virus
(TMV) RNA-based overexpression vector (TRBO) to express enzymatically active FLAG-
tagged plant made recombinant butyrylcholinesterase (rBChE) in Nicotiana benthamiana
leaves using transient agroinfiltration. Two gene expression cassettes were designed
to express the recombinant protein in either the ER or to the apoplastic compartment.
Leaf homogenization was used to isolate ER-retained recombinant butyrylcholinesterase
(prBChE-ER) while apoplast-targeted rBChE was isolated by either leaf homogenization
(prBChE) or vacuum-extraction of apoplastic wash fluid (prBChE-AWF). rBChE from
apoplast wash fluid had a higher specific activity but lower enzyme yield than leaf
homogenate. To optimize the isolation and purification of total recombinant protein
from leaf homogenates, an acidic extraction buffer was used. The acidic extraction
buffer yielded >95% enzymatically active tetrameric rBChE as verified by Coomassie
stained and native gel electrophoresis. Furthermore, when compared to human
butyrylcholinesterase, the prBChE was found to be similar in terms of tetramerization
and enzyme kinetics. The N-linked glycan profile of purified prBChE-ER was found
to be mostly high mannose structures while the N-linked glycans on prBChE-AWF
were primarily complex. The glycan profile of the prBChE leaf homogenates showed
a mixture of high mannose, complex and paucimannose type N-glycans. These findings
demonstrate the ability of plants to produce rBChE that is enzymatically active and
whose oligomeric state is comparable to mammalian butyrylcholinesterase. The process
of plant made rBChE tetramerization and strategies for improving its pharmacokinetics
properties are also discussed.
Keywords: butyrylcholinesterase, Nicotiana benthamiana, plant viral expression system, transient protein
production, plant N-glycosylation, tetramerization
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INTRODUCTION
Organophosphate (OP) nerve agents such as Sarin (Pohanka
et al., 2013) have been used in recent history against civilian
populations in Japan (Seto et al., 1999) and in Charbonneau
and Nichols (2013). Their acute toxicity is due to an irreversible
inhibition of human acetylcholinesterase (hAChE; Moshiri
et al., 2012), which leads to accumulation of acetylcholine in
the synaptic cleft followed by overstimulation of cholinergic
receptors and death if left untreated (Trovaslet-Leroy et al., 2011).
Although treatment options such as oximes, and atropine (Lenz
et al., 2007) are available, they are usually administered as post-
exposure prophylaxis and can have detrimental side effects such
as damage to the central nervous system (Trovaslet-Leroy et al.,
2011). A better treatment option is human butyrylcholinesterase,
(hBChE), a bio-scavenger that specifically and irreversibly binds
OP compounds with a MRT in the bloodstream of approximately
12 days (Duysen et al., 2002; Lenz et al., 2007; Saxena et al., 2008).
Human BChE is a glycosylated serine hydrolase that is
made in the liver and circulates in the bloodstream catalyzing
the hydrolysis of a variety of choline and non-choline esters
(Darvesh et al., 2003). It binds to OP compounds irreversibly at
a 1:1 stoichiometry (Çokugˇras¸, 203). Circulating human BChE
is a homotetrameric protein consisting of 85 kDa monomers
comprised of 574 amino acids (Ngamelue et al., 2007). Monomers
possess ten potential N-glycosylation sites of which, nine are
known to be occupied (Kolarich et al., 2008). Tetramerization
and sialylation of bi-antennary galactose residues on N-linked
glycans of hBChE are known to be essential for long MRT in the
bloodstream (Saxena et al., 2008). Because the concentration of
hBChE in the blood is very low, extracting and purifying gram or
kilogram quantities of hBChE from blood is impractical (Browne
et al., 1998). This has led researchers to explore heterologous
expression systems to produce functional recombinant hBChE in
amounts that are affordable and practical for protecting civilian
and military personnel from OP nerve agents. Some of these
expression systems include transgenic goats, Chinese hamster
ovary (CHO) cell culture, and human embryonic kidney cell
culture (Nachon et al., 2002; Chilukuri et al., 2005; Huang
et al., 2007). Although these systems are capable of producing
functional rBChE, their drawbacks include high fermentation
cost, slow cell growth rates, risk of viral infection of mammalian
cell cultures and long lag time between gene transfer and lactation
for transgenic animals (Houdebine, 2009; Thomas et al., 2011).
Plants, particularly Nicotiana benthamiana (N. benthamiana),
have been used to produce rBChE as well as other
biopharmaceutical proteins (Goldstein and Thomas, 2004).
Some of the advantages of the N. benthamiana expression system
are its affordability, low risk of carrying human pathogens,
its scalability and ability to glycosylate proteins (Raskin et al.,
2002; Obembe et al., 2011; Xu et al., 2012). prBChE produced
Abbreviations: Apo, apoplast; AWF, apoplast wash fluid; BChE, native
human butyrylcholinesterase; CBS, citric buffered saline; ER, endoplasmic
reticulum; eqBChE, equine butyrylcholinesterase; HRGP, hydroxyproline-rich
glycopeptides; MRT, mean residence time; PK, pharmacokinetics; prBChE, plant-
made recombinant butyrylcholinesterase; PRP, proline-rich peptides; rBChE,
recombinant butyrylcholinesterase; TBS, tris buffered saline.
from transgenic N. benthamiana has been tested successfully
as a bio-scavenger against multiple nerve agents (Geyer et al.,
2010a,b). However, growth and scale up of transgenic lines can
take several months (Garabagi et al., 2012) making it difficult
to response rapidly to new chemical or biological challenges to
human health. Alternatively, transient expression of prBChE
in N. benthamiana can be achieved in 4–12 days, making
transient expression systems well suited for rapid production of
biodefense agents like hBChE (D’Aoust et al., 2010; Pogue et al.,
2010; Schneider et al., 2014a,b). High level, rapid and transient
expressing of target proteins can be achieved in N. benthamiana
using a plant viral expression vector cloned in Agrobacterium
tumefaciens (A. tumefaciens; Hefferon, 2012). Examples of plant
viruses being used as viral expression vectors are Tobacco Mosaic
VirusTMV (Lindbo, 2007; Kagale et al., 2012), Cucumber Mosaic
Virus (CMV; Sudarshana et al., 2006; Hwang et al., 2012) and
the Gemini virus-based vectors (Huang et al., 2010). Vacuum
agroinfiltration is a fast and efficient mean for introducing
recombinant A. tumefaciens harboring a gene of interest into
plants. Transcription and translation of the gene starts within a
few hours post-infiltration (Arzola et al., 2011).
The aim of this study was to use a plant viral expression
system and purification strategies to express enzymatically
active, tetrameric prBChE using transient agroinfiltration in
N. benthamiana leaves. Two separate expression cassettes
were designed to express rBChE in the ER (i.e., ER-retained;
Figure 1A) or targeted to the apoplast (Apoplast-targeted;
Figure 1B). Expression cassettes were cloned into the viral vector,
TRBO, a TMV RNA-based overexpression vector (Lindbo, 2007).
Expression vectors with their cassettes were separately cloned
into A. tumefaciens and co-infiltrated into N. benthamiana leaves
with the silencing suppressor P19. The levels, specific activities of
differentially targeted prBChE (i.e., prBChE-ER vs. prBChE), and
differentially extracted apoplast targeted prBChE (i.e., prBChE vs.
prBChE-AWF), were estimated. Their N-linked glycan structures
were determined. The results of this study indicate that prBChE,
extracted from whole leaf homogenates was similar to the hBChE
and eqBChE controls in terms of physiochemical properties,
tetramerization and kinetic parameters.
MATERIALS AND METHODS
Construction of Gene Expression
Cassettes
Two gene expression cassettes were synthesized (GenScript,
Piscataway Township, NJ, USA) for both intracellular
and extracellular localization of prBChE. One cassette
(prBChE+KDEL) was designed to retain prBChE in the ER
(Figure 1A) while the other (prBChE) was used to target prBChE
to the apoplastic space (Figure 1B). The hBChE sequence (Gene
bank: NP_000046.1) lacking human signal peptide was codon
optimized to a codon-adjusted index of 0.87 (from 0.76) to
facilitate expression in N. benthamiana. In both expression
cassettes (Figures 1A,B), the signal peptide of hBChE was
replaced with the 75 base pair sequence coding for the rice
alpha-amylase RAmy3D signal peptide (Gene bank: M59351).
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FIGURE 1 | Map of gene constructs. (A) pTRBO-prBChE-KDEL, (B) pTRBO-prBChE, and (C) p35S-P19, 35S: Cauliflower Mosaic Virus (CaMV) promotor,
RAmy3DSP: rice alpha-amylase 3D gene signal peptide, Replicase: replicase gene of tobacco mosaic virus (TMV), MP: movement protein, BChE: codon optimized
sequences for the human butyrylcholinesterase gene. 3XFLAG: specific amino acid codon sequences used for immunodetection and purification of the protein.
KDEL: Codons encoding lysine, aspartic acid, glutamic acid, leucine, specifying the endoplamsmic retention sequence. P19: P19 gene from Tomato Bushy Stunt
Virus (TBSV).
The 3xFLAG tag sequence (Sigma–Aldrich, St. Louis, MO, USA)
was inserted between the RAmy3D signal peptide and hBChE
sequences in both cassettes.
Construction of Viral Vector Expression
Systems
To transcribe the two different rBChE expression cassettes,
the TMV-based plant viral vector system, TRBO, was used.
The binary vectors pTRBO-rBChE+KDEL (Figure 1A) and
pTRBO-rBChE (Figure 1B) were made as follows. The hBChE
cassette and the backbone vector, pTRBO, were digested with
AvrII and PacI restriction enzymes after which the inserts
were ligated to the pTRBO yielding pTRBO-rBChE+KEDL and
pTRBO-rBChE viral expression vectors (Figures 1A,B). The
recombinant vectors were transformed to DH5α Escherichia
coli competent cells (Invitrogen, Carlsbad, CA, USA) following
manufacturer specifications. A. tumefaciens EHA105 was used for
transformation as described earlier (Shen and Forde, 1989). To
prevent the RNAi-mediated gene silencing defense mechanism
in plants, the silencing suppressor gene, P19, under the control
of the 35S promoter (Arzola et al., 2011; Figure 1C) was co-
infiltrated with the TRBO viral expression vector.
Agroinfiltration and Incubation of N.
benthamiana Plants
Agrobacterium tumefaciens (EHA105) cells containing pTRBO-
rBChE+KDEL, pTRBO-rBChE, and p35S-p19, were grown in
5 ml LB media having the appropriate antibiotics for 24 h with
shaking (250 rpm) at 28◦C. The cultures were transferred into
200 ml LB media having 40 µM of acetosyringone (Sigma–
Aldrich, St. Louis, MO, USA) grown overnight at 28◦C with
shaking (250 rpm). Cells were harvested by centrifugation at
2,600 g and resuspended in sterile, 10 mM MES buffer (Fisher
Scientific, Santa Clara, CA, USA) pH 5.6, 10 mM MgCl2
and 150 µM acetosyringone to achieve an OD600 of 0.5. The
TRBO expression cassette (pTRBO-rBChE+KDEL or pTRBO-
rBChE) was mixed in a 1:1 volume ratio with the gene-silencing
suppressor (p35S-p19). The mixed agrobacterium suspensions
were incubated in the dark for 1 to 3 h before infiltration.
To validate and compare the viral expression of the two TRBO
expression cassettes, three, 4–5 weeks old, N. benthamiana plants
were used per experiment. The plants were grown in four-inch
pots in a greenhouse under 16/8 h (light/dark) cycle. The potted
plants were inverted and immersed in 600 ml of the agrobacteria
solution containing 0.02% of Silwet-L-77 (Lehle seeds, Round
Rock, TX, USA) and placed in a Nalgene container for vacuum
application (−25 in Hg) for 2 min before releasing the vacuum.
The agroinfiltrated plants were incubated in an environmental
growth chamber at 90% humidity and 21◦C for 6 days after
which the leaves were cut at the petioles and harvested. The
agroinfiltrated leaves were stored at −80◦C for further analysis,
or were immediately processed to recover apoplastic fluids.
Extracting prBChE from agroinfiltrated
N. benthamiana Leaves
Plant-derived BChE was extracted from N. benthamiana leaves
using two extraction methods. First, leaf homogenates (prBChE-
ER and prBChE) were extracted by grinding leaves frozen in
liquid nitrogen with the extraction buffer TBS-1 (20 mM Tris-
HCl, pH 8, 150 mM NaCl, 0.01% Tween 80) at a ratio of 1 g leaf
tissue to 4 ml buffer. The extract was mixed for 30 min at 4◦C
before centrifugation at in 3,200 g for 30 min at 4◦C. Supernatant
was recovered and stored at 4◦C for subsequent analysis.
Apoplast Wash Fluid Recovery (AWF) of
prBChE from Agroinfiltrated N.
benthamiana Leaves
prBChE-AWF was extracted as follows: freshly harvested
agroinfiltrated leaves were submerged in a harvest buffer, TBS-
2 (20 mM Tris-HCl, pH 8, 150 mM NaCl, 0.02% Silwet L-77) and
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placed in a Nalgene container for a 2 min vacuum application.
The infiltrated leaves were placed in 50 ml falcon tubes, and
centrifuged for 15 min at 4◦C at 250 g. The AWF was recovered
and stored at 4◦C.
Quantification of Plant Soluble Proteins
Total soluble protein concentration was determined by the
Bradford assay (Bio-Rad, Hercules, CA, USA) using bovine
serum albumin (BSA; Sigma–Aldrich, St. Louis, MO, USA) as a
standard. A standard curve was generated using BSA solutions
ranging from 0.05 to 0.5 mg/ml. The absorbance of the standards
and samples was measured at 595 nm with a SpectraMax 340C
spectrophotometer (Molecular Devices, Sunnyvale, CA, USA).
In Vitro Activity Assay of prBChE Protein
A modified Ellman assay (Ellman et al., 1961) was
used to quantify the activity of butyrylcholinesterase.
S-Butyrylthiocholine (BTCh) iodide (Sigma–Aldrich, St.
Louis, MO, USA) and 5, 5′-dithiobis-2-nitrobenzoic acid
(DTNB; Sigma–Aldrich, St. Louis, MO, USA) dissolved in 0.1 M
phosphate buffer, pH 7.4 were used to make a working substrate
solution at 0.5 and 0.267 mM, respectively. A volume of 150 µl
of the working substrate solution was added to 50 µl of enzyme
diluted with phosphate buffer in 96-well plates and the progress
of the reaction was monitored in triplicates at 405 nm for 5 min
at 25◦C. A specific activity of 260 U/mg was used to convert from
units of activity to mg rBChE.
SDS-PAGE and Western Blot Analysis
Protein samples and controls were subjected to SDS-PAGE using
a 4–15% gradient gel (Bio-Rad, Hercules, CA, USA) under non-
reducing and reducing conditions with 5% β-mercaptoethanol
(Bio-Rad, Hercules, CA, USA). Briefly, protein samples and
controls were heated for 5 min at 95◦C and electrophoresis
performed for 35 min at 200 V. Gels were either stained in
Coomassie Brilliant Blue G-250 (Bio-Rad, Hercules, CA, USA)
or transferred to a 0.45 µm nitrocellulose membrane (Bio-
Rad, Hercules, CA, USA) for 90 min at 100 V. Blots were
blocked with 5% non-fat dry milk (NFDM) in (1X) PBS, pH 7.4.
overnight and washed three times with (1X) PBST buffer at 5-min
intervals. The blots were developed with either 1:2,500 dilution of
monoclonal anti-FLAG M2-Peroxidase (HRP) antibody (Sigma–
Aldrich, St. Louis, MO, USA) in 5% NFDM solution or with
1:200 mouse monoclonal anti-BChE antibody (D-5; Santa Cruz
biotechnology, Santa Cruz, CA, USA) in 5% NFDM solution
followed by 1:2000 goat anti-mouse HRP conjugated secondary
antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) in
5% NFDM solution. The blots were incubated for 1 h at room
temperature in each antibody solution after which the blots
were washed with (1X) PBST buffer three times for 5 min each.
TMB stabilized substrate for horseradish peroxidase (Promega,
Madison, WI, USA) was used as a color development substrate.
Commercially available eqBChE (Sigma–Aldrich, St. Louis, MO,
USA) and PEGylated goat-made butyrylcholinesterase (PEG-
rBChE) kindly provided by Dr. Doug Cerasoli (USAMRICD)
were used as controls.
Purification of prBChE from Total Leaf
Homogenates and AWF
To determine the optimal extraction buffer, the following
two extraction buffers were used; 50 mM Tris-HCl, pH 8,
250 mM NaCl with 0.01% Tween 80 (TBS-3) and 50 mM
citric buffer, pH 4, 250 mM NaCl with 0.01% Tween 80
(CBS). Frozen agroinfiltrated leaves with TRBO constructs
with (prBChE+KDEL) and without KDEL sequence (prBChE)
were used to purify prBChE-ER and prBChE from total leaf
homogenate. Biomass was ground in liquid nitrogen at a ratio of
1 g:4 ml buffer and the amount of enzymatically active prBChE
from total leaf homogenate and total soluble proteins were
determined.
Based on the buffer screening experiments, CBS buffer was
selected for protein recovery from homogenized leaves. The
crude extracts (prBChE-ER and prBChE) were filtered through
a 0.22 µm filter (EMD Millipore, Chicago, IL, USA) followed
by filtration through a 30 kDa Minimate Tangential Flow
Filtration Capsule (Pall Corporation, Ann Arbor, MI, USA). The
concentrated retentate was loaded on ANTI-FLAG M2 affinity gel
(Sigma–Aldrich, St. Louis, MO, USA) and the target protein was
captured and eluted based on the manufacturer’s specifications.
Similarly, the recombinant protein from the AWF was filtered,
concentrated using a 30 kDa Amicon centrifugal filter units
(EMD Millipore, Chicago, IL, USA) and purified using ANTI-
FLAG M2 affinity gel (Sigma–Aldrich, St. Louis, MO, USA).
Glycopeptide Analysis
Sample Preparation
Glycopeptide analysis of the different prBChE products was
performed according to the method described by Nwosu et al.
(2013) with a few modifications. Briefly, 5 µg of each prBChE
sample was denatured for one h at 57◦C in the presence
of dithiothreitol. Alkylation was achieved by iodoacetamide
addition and incubation in the dark. The alkylated samples
were run on SDS-PAGE and Any-kD Mini Protean TGX gels
(Bio-Rad, Hercules, CA, USA). After staining with Coomassie
Brilliant Blue G-250 (Bio-Rad, Hercules, CA, USA) and rinsing
in water, the targeted protein bands were excised from the gel,
rinsed and destained using alternating washes (three cycles) of
100 mM ammonium bicarbonate (pH 8.0) and pure acetonitrile.
Finally, the excised gel pieces were completely dried under
vacuum and treated with 100 µl of a 0.005 µg/µl Pronase
(Sigma–Aldrich, St. Louis, MO, USA) solution in 100 mM
ammonium bicarbonate (pH 8.0). Digestion was allowed to
proceed overnight at 37◦C. The supernatant was withdrawn and
dried in a SpeedVac (Genevac EZ-2, Stone Ridge, NY, USA) prior
to the MS analysis.
Mass Spectrometry
Dried samples were reconstituted in 10 µl of deionized water and
were analyzed using an Agilent 6520 Q-TOF mass spectrometer
(Agilent Technologies, Santa Clara CA, USA). Tandem MS
analysis of the samples was acquired in the positive mode
in a data-dependent manner following LC separation on a
microfluidic chip packed with porous graphite carbon (PGC),
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(Agilent Technologies, Santa Clara CA, USA). The two solutions
pumped in these analyses consist of a binary solvent: A,
3.0% ACN/water (v/v) with 0.1% formic acid (FA); B, 90%
ACN/water (v/v) with 0.1% FA. A flow rate of 3 µl/min of
solvent A was used for sample loading with a 10 µl injection
volume. Samples were eluted with 1% B (0.00–2.50 min); 1–
16% B (2.50–20.00 min); 16–44% B (20.00–30.00 min); 44–
99% B (30.00–35.00 min), and 99% B (35.00–45.00 min). Mass
calibration was enabled using infused reference masses (ESI-
TOF tuning mix G1969-85000, Agilent Technologies, Santa
Clara CA, USA). For the tandem MS analysis, ions were
subjected to collision-induced fragmentation using collision
energies (Vcollision) that were dependent on the m/z value of the
quasimolecular ions according to the equation Vcollision = m/z
(1.8/100 Da) V–2.4 V. The preferred charge states were set at 2, 3,
and>3.
Data Analysis
Glycopeptides were assigned based on a combination of accurate
mass measurement and tandem MS data. In-house developed
software (Glycopeptide Finder; Strum et al., 2013) was used
for rapid and automated assignment of the glycopeptides.
The assignments were made within a specified tolerance level
(≤20 ppm). To identify glycopeptides in the tandem MS data,
product ion spectra were sorted by the presence of carbohydrate-
specific oxonium fragment ions. The glycan moieties of the
glycopeptides were confirmed by the presence of B-type and
Y-type ions derived from the sequence of glycan fragmentations
in the product ion spectra. However, the peptide moieties were
mainly confirmed using accurate measurement of their masses
in the tandem MS data. Identifications with a confidence level
of 95% (based on the Glycopeptide Finder decoy analysis) were
considered.
Determination of Enzymatic Parameters
of Plant Recombinant BChE Protein
The kinetic parameters of hBChE and prBChE were determined
using a modified Ellman assay described previously. For these
determinations, different concentrations of the substrate (BTCh)
ranging from 0 to 7.5 mM were used in a 0.267 mM DTNB
dissolved in 0.1 M phosphate buffer, pH 7.4. The progress of
the reactions was monitored at the same conditions (T = 25◦C
and pH 7.4 for 5 min). Initial reaction rates were determined in
triplicate at each substrate concentration and were plotted and a
non-linear regression analysis was applied using GraphPad Prism
ver.6 (La Jolla, CA, USA).
Oligomeric State of prBChE Protein
The relative amounts of purified prBChE monomers, dimers,
and tetramers were estimated by running hBChE and eqBChE
(Sigma–Aldrich, St. Louis, MO, USA) as controls on a native
gel. A 7.5% gel (Bio-Rad, Hercules, CA, USA) was used and
electrophoresis was performed at 40 V for 7 h at 4◦C. The gel
FIGURE 2 | Quantification of active prBChE protein in crude extracts using TRBO viral system as a function of sublocalization in plant cell and
extraction methodology. A modified Ellman assay was used to determine the accumulation level of active prBChE protein species localized in different
sub-compartments in plant cells in N. benthamiana leaves agroinfiltrated with TRBO expression system. The apoplast-targeted prBChE was extracted either by leaf
homogenization or collecting the AWF. Specific activity was determined as the ratio of active protein estimated from the Ellman assay relative to total soluble protein
estimated by Bradford assay. All data plotted are the average of three independent measurements ± SD.
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FIGURE 3 | (A) SDS-PAGE and (B) Western blot of different variants of
prBChE protein. (A) Coomassie stained gel with 7 µg total soluble protein
(TSP) of prBChE-AWF (lanes 1) and total leaf extract of prBChE (lanes 2)
loaded into each well under non-reduced conditions. Lane M shows the
pre-stained protein molecular weight standards along with the molecular
weight in kDa. (B) Western blot analysis using 1:2,500 anti-FLAG HRP
conjugated antibody.
was either stained with Coomassie Brilliant Blue G-250 (Bio-Rad,
Hercules, CA, USA) or according to the method of Karnovsky
and Roots (Karnovsky and Roots, 1964). The western blot was
developed as described earlier.
RESULTS
Quantifying Differentially Targeted
prBChE in Agroinfiltrated N.
benthamiana Leaves
The amount of active and differentially targeted prBChE (i.e.,
with and without the KDEL sequence) produced by TRBO
was determined. Total protein from leaf homogenates were
extracted with TBS-1 and the level of active prBChE-ER was
found to be approximately the same as the prBChE enzyme
(Figure 2). In addition to isolating apoplast-targeted prBChE
from agroinfiltrated N. benthamiana leaf homogenates, vacuum
FIGURE 4 | (A) SDS-PAGE and (B) Western blot of ER retained and apoplast
targeted prBChE protein extracted using different extraction buffers.
(A) Coomassie stained gel with 15 mU: lane1: (prBChE-ER pH 4 extract),
lane 2: (prBChE-ER pH 8 extract), lane 3 (prBChE pH 4 extract), lane 4
(prBChE pH 8 extract), lane 5: (3 µg of equine BChE control) loaded under
non-reduced conditions. Lane M shows the pre-stained protein molecular
weight standards along with the molecular weight in kDa. (B) Western blot
analysis using 1:200 mouse anti-BChE antibody and 1:2,000 goat anti-mouse
HRP conjugated antibody.
infiltration in TBS-2 was used to obtain prBChE in the
apoplast wash fluid (prBChE-AWF). The amount of prBChE-
AWF was two orders of magnitude lower than that recovered
from whole leaf homogenates, which shows that this protein is
poorly secreted to the apoplast (Figure 2). Due to the lower
amount of total protein extracted from the AWF, the specific
activity of the prBChE-AWF was approximately twice that
obtained from leaf extracts (Figure 2). It is worth noting that
and intercellular plant proteins like RuBisCo (large subunits
around 50 kDa) were not detected in the AWF (Figure 3A).
This may explain the higher specific activity obtained for
prBChE-AWF compared to total leaf homogenates (Figure 2).
Figure 3 compares the prBChE obtained from the total leaf
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extract with that recovered from the AWF. As can be seen in
Figures 3A,B, less prBChE was recovered using AWF method
compared to prBChE obtained from homogenizing whole leaf
tissue.
Purification, SDS-PAGE Analysis and
LC-MS/MS Analysis of Purified prBChE
Protein
Although the specific activity of prBChE-AWF was higher
than that from leaf homogenates, it was not used for large-
scale purification because of its low yield per unit mass.
The two extraction buffers, TBS-3 (pH 8) and CBS (pH 4)
were used to extract the leaf homogenates. As shown in
Figure 4A, many intercellular proteins were extracted by total
leaf homogenization using TBS-3 pH 8. Extracting prBChE in
a high pH buffer and in the presence of many contaminating
intercellular proteins (e.g., RuBisCo) lowered the specific activity
of prBChE. A comparison of the extractability of enzymatically
active prBChE using these two extraction methods is shown
in Figures 4A,B. The SDS-PAGE analysis (Figure 4A) shows
that RuBisCo was not extracted by the CBS buffer in contrast
to the TBS-3 buffer extraction. As can be seen in Figure 4A,
there were no prominent proteins migrating around the
50 kDa marker when extracting tobacco leaves with the acidic
buffer.
Once the leaf homogenate extraction buffer was optimized,
prBChE variants (i.e., prBChE-ER and prBChE) were extracted
using the CBS buffer and purified using ANTI-FLAG affinity
gel, in addition to purification of prBChE from the AWF.
The purified prBChE protein variants were compared to a
dilution series of PEG-rBChE protein standard. Although only
7 µg (based on activity) were loaded in lanes 1 and 2
(Figures 5A,B), the Western blot shows more intense bands
for prBChE when compared to PEG-rBChE bands possibly
indicating a less active form of the protein in the prBChE
samples.
Glycopeptide Analysis of Different
Subcellular Localized prBChE Protein
For each sample, several glycopeptide compositions were
identified. As some of the peptide moieties overlap in mass
within the 20 ppm tolerance, site-specific information could
not be determined. Nevertheless, as the glycan moieties
were unambiguously identified, they were used to compare
glycosylation patterns among the different prBChE samples.
Extracted glycopeptide ion intensities were grouped and summed
up by the composition of the glycan moiety and normalized
for comparison. The variation in subcellular localization resulted
in different glycosylation patterns on the recovered prBChE
(Figure 6). As expected, the prBChE-ER showed mainly
high-mannose structures (>90%) with small percentages of
paucimannosidic-type N-linked glycan and complex N-linked
glycans. The majority of the high mannose N-linked glycans had
6–8 mannose residues. Alternatively, prBChE-AWF consisted
mostly of complex type N-linked glycans. Finally, prBChE
yielded a mixture of different N-linked glycan types. Nearly
FIGURE 5 | (A) SDS-PAGE and (B) Western blot of purified prBChE protein
compared to serial dilutions of PEG-rBChE protein control. (A) Coomassie
stained gel: lanes 1 and 2 contain duplicate loadings of 7 µg of prBChE
protein. Lanes 3 to 6 contain serial dilutions of PEG-rBChE control (lane 3: 1,
lane 4: 3, lane 5: 7, and lane 6: 10 µg), all loaded under reduced conditions.
Lane M shows the pre-stained protein molecular weight standards along with
the molecular weight in kDa. Because the goat recombinant BChE is
PEGylated, its monomeric mobility on SDS-PAGE is approximately 200 kDa.
However, the unPEGylated goat BChE co-migrates with prBChE as revealed
by SDS-PAGE. (B) Western blot analysis using 1:200 mouse anti-BChE
antibody and 1:2,000 goat anti-mouse HRP conjugated antibody.
25% of the N-linked glycans were high-mannose structures,
which are characteristic of the ER-retained prBChE protein.
For prBChE, approximately 40% of the total observed N-linked
glycans were complex N-linked glycans. A significant amount
(approximately 35%) of paucimannosidic-type N-linked glycans
was also found in the apoplast-targeted prBChE. The difference
in the N-glycosylation between prBChE and prBChE-apoplast-
targeted-AWF can be explained by differences in glycan
processing as the protein moves along the secretory pathway from
the ER to the trans-Golgi network.
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FIGURE 6 | N-glycan distribution analysis of different prBChE species. (A) Categories of N-glycans for each prBChE species are represented as pie charts.
(B) Distribution of N-glycans of different prBChE species [prBChE-ER (ER), prBChE-AWF (AWF) and prBChE (Apo)] is shown on y-axis, while x-axis represents
nomenclature of N-glycans as (Hex/HexNAc/Fucose/xylose).
Enzymatic Properties and Oligomeric
State of prBChE Protein
The prBChE protein variant was selected for further
characterization since it contains the highest amount of
complex N-linked glycans, which are suitable for further
in vitro modification including sialylation. The kinetics of
butyrylthiocholine (BTCh) hydrolysis by prBChE was compared
to the hBChE serum control. As previously described by Radic
et al. (1993), BChE enzyme kinetics conforms to a substrate
activation kinetic model when BTCh is used as a substrate.
The rate of reaction was monitored over a large substrate
concentration that ranged from 10 µM to 7.5 mM (Figure 7).
Non-linear regression analysis shows that the Km of prBChE
for BTCh was (39 ± 19) µM, compared to the hBChE control
(61 ± 40 µM). However, the turnover number of BTCh
hydrolysis (kcat) for serum-derived hBChE was higher than that
of prBChE.
Different oligomers of prBChE were observed by fractionating
the protein by SDS-PAGE under reduced and non-reduced
conditions and on corresponding immunoblots (Figure 8).
Under non-reduced conditions, the prBChE was observed
migrating as monomeric, dimeric, and possible tetrameric
structures. While under reducing conditions, the monomers of
prBChE were the predominant form due to the reduction of
intermolecular disulphide bonds. To estimate the various types
and proportions of prBChE oligomers, native PAGE analysis was
performed under non-denaturing conditions. The recombinant
protein showed an oligomeric state similar to that of the human
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FIGURE 7 | Initial reaction velocity kinetics of BTCh hydrolysis by BChE enzyme. The hydrolysis rate of BTCh substrate was monitored by measuring BChE
activity (prBChE vs. human BChE control) over a large substrate concentration (10 µM–7.5 mM) in 0.1 M phosphate buffer pH 7.4, 0.267 mM DNTB.
and equine serum controls. Almost all the protein was in the
tetrameric state (Figures 9A–C). Denatured prBChE and the
equine serum control were analyzed using native PAGE and the
migration patterns were found to be similar (Figure 10). This
indicates that the native form of prBChE is a tetrameric protein.
Furthermore, native gel electrophoresis was used to separate
the various molecular species in the crude leaf homogenate.
This revealed only tetrameric prBCHE relative to the eqBChE
(Figures 11A,B).
DISCUSSION
In the quest for a safe, abundant and affordable source
of rBChE from plants, studies by the Lockridge group
(Blong et al., 1997; Ngamelue et al., 2007; Biberoglu et al.,
2012; Larson et al., 2014) and others (Masson et al., 2003;
Schneider et al., 2014a,b) have focused attention on the
desirable pharmacokinetic (PK) properties of prBChE. For
prBChE, desirable PK properties include functionality, reduced
risk of immunogenicity-allergenicity and longer MRT in the
bloodstream afforded by sialylation of terminal galactose residues
on N-linked glycans (Schneider et al., 2014a) and tetramerization
of the BuChE monomers. The production of large quantities of
any plant-made biopharmaceutical lacking its key PK properties
does little to provide effective therapeutic solutions to natural or
man-made threats to human health.
In this report, we described the expression of rBChE in
N. benthamiana in a manner that yielded enzymatically active
protein that was greater than >95% tetrameric (Figures 9–11).
Enzymatic activity and electrophoretic mobility, on native gels,
was similar to that seen with eqBChE and hBChE controls
(Figures 9–11). In terms of yield, the TRBO expression vector
produced prBChE-ER at 0.78 U/mg total soluble protein, which
was comparable to that obtained by Geyer et al. (2010a; geometric
FIGURE 8 | Oligomer distribution analysis by Western blot using (A)
non-reducing and (B) reducing conditions SDS-PAGE analysis. Western
blot analysis was developed using 1:200 mouse anti-BChE antibody and
1:2,000 goat anti-mouse HRP conjugated antibody of 0.25 µg of equine
BuChE control (lane 1) and 0.25 µg pure prBChE protein (lane 2). Lane M
shows the pre-stained protein molecular weight standards along with the
molecular weight in kDa.
mean = 0.7 U/mg protein) for the expression of ER retained
prBChE from transgenic N. benthamiana.
Our findings are generally consistent with those of (Geyer
et al., 2010b) who showed that approximately 50% of their
prBChE purified from N. benthamiana leaf homogenates was
enzymatically active tetramer. Like (Schneider et al., 2014b), the
presence of a FLAG tag on the N-terminus of our prBChE did not
affect its enzymatic activity or ability to be purified. Although we
observed only tetrameric prBChE on native gels (Figure 11B) in
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FIGURE 9 | (A) Coomassie stained, (B) Western blot, and (C) activity stained Native gel analysis of prBChE, compared to BChE control. (A,B) Coomassie stained
and Western blot 7.5% gel with 3 µg of purified prBChE (lane 3) compared to BChE mammalian serum enzymes (1.5 µg of human protein: lane 1, 3 µg equine
protein: lane 2). (C) Activity stained of 0.25 mU pure prBChE (lane 2) and 0.25 mU equine control (lane 1).
FIGURE 10 | (A) Coomassie stained and (B) Western blot of Native gel
analysis of denatured prBChE, compared to denatured equine BChE control.
(A) Coomassie stained gel, lane 1: 1 µg equine BChE control under native
conditions, lane 2: 1 µg of denatured equine BChE control under reducing
conditions, lane 3: 1 µg prBChE under native conditions, lane 4: 1 µg of
denatured prBChE under reducing conditions. (B) Western blot analysis
developed with 0.5 µg equine BChE control and prBChE using 1:200 mouse
anti-BChE antibody and 1:2,000 goat anti-mouse HRP conjugated antibody.
all of our extracts (ER, AWF, and Apo), we cannot compare our
findings to those of (Schneider et al., 2014b) because of significant
different between our protocols. For example, the protocols of
(Schneider et al., 2014b) used non-reducing gel electrophoresis
to estimate oligomerization status while we used native gels. In
addition, different viral-based expression vectors were used. At
present, there is no clear explanation for these differences in
oligomeric status and yield between our findings and (Schneider
et al., 2014b). Additional experiments are underway to identify
the factor(s) responsible for these differences.
A more fundamental question is how monomers of an
85 kDa mammalian enzyme oligomerize into tetramers in
the milieu of the plant ER. Although determining the
mechanism of prBChE tetramerization in planta is beyond
the scope of this report, two possible explanations should
be considered. First, oligomerization of mammalian proteins
like hBChE may tetramerize in the ER or during transport
through the secretory pathway. This can be supported by
N-glycan profiling of the purified prBChE, which shows 25%
of its N-glycans with high mannose structures (Figure 6).
Alternatively, prBChE dimers may form tetramers as cellular
contents are released by homogenization into the extraction
environment. Regardless of which possibility is correct, both
possibilities require that the entropic penalty of organizing
prBChE into highly enthalpic tetramers, be paid by reducing
ordered water molecules in and around prBChE as it proceeds
along the assembly pathway (Ali and Imperiali, 2005; Fatmi and
Chang, 2010). Furthermore, whether in plant or mammalian
cells, the oligomerization of proteins is highly complex, sensitive
to numerous intracellular and extracellular factors such as;
protein concentration, temperature, pH, hydrogen and ionic
bonding, hydrophobic interactions, phosphorylation, domain
swapping and ligand binding (Ali and Imperiali, 2005; Gotte
and Libonati, 2014). While BChE dimers are formed from
intermolecular disulfide bonds at Cys571, tetramer assembly
involves non-covalent affects and interactions such as those
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FIGURE 11 | (A) Western blot analysis of a native gel of crude preparation of
prBChE. Western blot analysis was performed using 1:200 mouse anti-BChE
antibody and 1:2,000 goat anti-mouse HRP conjugated antibody of crude
extract preparation of 0.25 µg prBChE (lane 3) compared to 0.25 µg of
equine control (lane 1) and 0.25 µg pure prBChE protein (lane2). (B) Native
gel analysis of different prBChE variants. 45 mU of prBChE-ER (lane 1),
prBChE (lane 2), prBChE-AWF (lane 3) and equine control (lane 4) were
loaded to a 7.5% gel and stained for BChE activity according to the method of
Karnovsky and Roots (1964).
described above. A priori, this makes tetramerization of BChE
highly sensitive to these factors and difficult to predict and
control. Interestingly, the pH of the ER and trans-Golgi network
has been found to be a gradient from the ER to the plasma
membrane of 7.2 to 5.2 in mammals (Paroutis et al., 2004) and
6.8 to 5.2 in plants (Bassil et al., 2012). Whether a pH gradient
contributes in any way to BChE tetramerization is a matter of
speculation at this time.
Regarding ligand binding, it has been well documented
that hBChE contains a C-terminal tetramerization domain that
interacts non-covalently with small, naturally occurring PRP
12 to 21 residues long in vivo the to promote tetramerization
(Nicolet et al., 2003; Dvir et al., 2004; Pan et al., 2009;
Biberoglu et al., 2012). It was further shown that these PRPs
do not merely catalyze tetramerization but become part of the
BChE tetrameric complex. In another study, synthetic PRPs
ranging from 15 to 50 residues were used to promote in vitro
tetramerization of CHO cell-derived rBChE in a concentration-
, temperature-, and time-dependent manner (Larson et al., 2014).
These results are consistent with studies on the oligomerization
of multi-subunit enzymes that showed that ligand binding
lowers the conformation transition barrier and helps the protein
conformation shift from its inactive to its active form (Ali and
Imperiali, 2005; Fatmi and Chang, 2010). This interaction may
help explain the role of PRPs in the tetramerization of rBChE
from mammalian sources.
The implications of these studies are important for those
planning to use plants to express prBChE in that it suggests
the tetramerization of hBChE is dependent on its non-covalent
interaction with a PRP, the likes of which have not been
observed in plants. Although hydroxyproline-rich, O-linked,
glycopeptides (HRGP) are found in both monocotyledonous and
dicotyledonous plants, they are largely interspersed repeats of
hydroxyproline (Albenne et al., 2009), not the tandem repeats
found in the PRPs associated with native human BuChE. Another
interesting feature of plant HRGPs is that the hydroxyproline
repeats are frequently interspersed with charged amino acids
(e.g., lysine and glutamic acid) making them sensitive to changes
in pH. The fact that tetrameric prBChE can be detected in
N. benthamiana leaf extracts (Geyer et al., 2010a,b; Schneider
et al., 2014b) raises the possibility that plant HRGPs can
substitute for mammalian PRPs to promote tetramerization of
prBuChE dimers. We hypothesize that the plant ER can pay the
entropic penalty of oligomerization by drawing upon its vast
array of processes, mechanisms, signals and possibly HRGPs, to
tetramerize prBChE in a concentration-, temperature-, and pH-
dependent manner. Studies are currently underway to investigate
these independent variables on oligomerization of BChE in plants
tissues and plant cell suspension cultures.
CONCLUSION
The objective of this study was to investigate methods for
expressing active, tetrameric prBuChE in N. benthamiana leaf
homogenates and AWF with the goal of increasing its desirable
PK properties. We were able to produce prBChE variants using
TRBO viral expression vector and purified to near homogeneity
using affinity chromatography. The pure prBChE was found
to be a tetramer protein as shown by Coomassie stained
SDS-PAGE gels and native gel electrophoresis. We understand
that there are other strategies for making prBChE a “bio-
better” therapeutic using glycan engineering of plant N-linked
glycans. For example, the galactose residues on the terminal
N-linked glycans on prBChE can serves as substrate for in vitro
(Malekan et al., 2013), or in vivo (Paccalet et al., 2007; Schneider
et al., 2014a) sialylation to help extend the MRT of prBChE
in human blood. Also, N. benthamiana fucosyl-transferase
and xylosyl-transferase (1FT/XT) knock-down lines can be
used to produce prBChE with reduce immunogenicity and/or
allergenicity (Schneider et al., 2014b). While the 3XFLAG was
used to facilitate purification of prBChE, it can be removed
enzymatically prior to its use as an injectable therapeutic
to reduce risk of immunogenicity. Lastly, the expression of
biopharmaceuticals like prBChE in plant cell suspension cultures
using well-established fermentation technology may be the
shortest path to achieving scalability, affordability and regulatory
approval of a plant-made biopharmaceutical like prBChE. We
believe that all expression, purification and production options
should be explored to help meet the global demand for the next
generation of safe, efficacious and affordable biopharmaceuticals
derived from plants.
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